NCT02941887

Brief Summary

This study aimed at correlating global behavior of Down's Syndrome patients to periodontal disease status.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

October 19, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 21, 2016

Completed
Last Updated

October 24, 2016

Status Verified

October 1, 2016

Enrollment Period

3 years

First QC Date

October 19, 2016

Last Update Submit

October 21, 2016

Conditions

Keywords

Social behaviorGingivitisPeriodontitisDown's Syndrome

Outcome Measures

Primary Outcomes (2)

  • Periodontal disease (gingivitis and periodontitis) measured by a periodontal probe and classified according to severity

    Severe periodontitis was defined by the presence of ≥ 2 interproximal sites in different teeth with clinical attachment level (CAL) ≥ 6mm and ≥1 interproximal site with pocket probing depth (PPD) ≥5mm. Moderate periodontitis was defined by the presence of ≥ 2 interproximal sites in different teeth with CAL ≥ 4mm or ≥ 2 interproximal sites in different teeth with PPD ≥5mm. Mild periodontitis was defined as ≥ 2 interproximal sites in different teeth with ≥ 3 mm CAL and ≥ 2 interproximal sites in different teeth with ≥ 4 mm PPD or at least 1 site with PPD ≥ 5 mm (20,21). Gingivitis was determined as follows: Subjects were considered healthy if presented PPD ≤3mm/BOP extent scores \< 10% and with gingivitis if presented PPD ≤3mm/ bleeding on probing (BOP) extent scores \>10%. Prevalence of periodontal disease was the sum of gingivitis, mild, moderate and severe periodontitis.

    One day

  • Global behavior - observation and scoring based on a behavior scale

    Behavioral aspects: Interaction to evaluator, Communicative intention, Attention time, Response to conversation, Comprehension of concrete/no concrete situations with/without visual support, Parental interference, Acceptance of activities, Mimic, Eye contact, Participation in the dialogue (speech), Logical time sequence, Dialogue keeping, Word production Scores: 0 - absence, 1 - strictly presented, 2 - evidently presented.

    One day

Study Arms (1)

Down's Syndrome

Behavior analysis in Down's Syndrome patients

Behavioral: Behavior Analysis

Interventions

One examiner observed global behavior of patients during a dental care session, guided by a behavioral scale.

Down's Syndrome

Eligibility Criteria

Age15 Years - 52 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Patients with a medical diagnose of Down's Syndrome

You may qualify if:

  • Down's Syndrome Diagnose characterized by the whole chromosomal aneuploidy 15 to 52 years
  • Absence of severe hearing loss could impair the comprehension about the dental treatment
  • Absence of severe visual loss that could impair the comprehension about the dental treatment
  • Presence of at least four teeth being one for hemiarch.
  • Diagnose of gingivitis and periodontitis
  • Absence of acute periodontal disease and necrotizing periodontal disease.

You may not qualify if:

  • Smokers
  • Use of alcohol
  • Menopause
  • Pregnancy
  • Absence of all teeth
  • Uncontrolled diabetes mellitus
  • Uncontrolled hyperthyroidism
  • Angina
  • Uncontrolled hypertension
  • Coagulopathy
  • Use of illicit drugs
  • Head and neck radiotherapy
  • Chemotherapy
  • Non-cooperative patients or patients with other diseases as autism.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bauru School of Dentistry

Bauru, São Paulo, 17012-901, Brazil

Location

Related Publications (1)

  • Startin CM, Rodger E, Fodor-Wynne L, Hamburg S, Strydom A. Developing an Informant Questionnaire for Cognitive Abilities in Down Syndrome: The Cognitive Scale for Down Syndrome (CS-DS). PLoS One. 2016 May 6;11(5):e0154596. doi: 10.1371/journal.pone.0154596. eCollection 2016.

    PMID: 27153191BACKGROUND

MeSH Terms

Conditions

BehaviorPeriodontal DiseasesSocial BehaviorGingivitisPeriodontitisDown Syndrome

Interventions

Applied Behavior Analysis

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesInfectionsGingival DiseasesIntellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesChromosome DisordersGenetic Diseases, Inborn

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

October 19, 2016

First Posted

October 21, 2016

Study Start

October 1, 2013

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

October 24, 2016

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will not share

Locations